Skip to Content

Do you allow analytics?

We use analytics tools to understand how people use the site. They're optional: if you decline, the site works the same, no analytics cookies are set and Google gets only a cookieless, anonymous count signal. Your votes are saved either way; the details are in the privacy policy.

Referandom is here: Tinder for Congress 🔥

Support Referandom
EconomyH.R. 919Comments

Chronic Disease Flexible Coverage Act

Official title: To codify Internal Revenue Service guidance relating to treatment of certain services and items for chronic conditions as meeting the preventive care deductible safe harbor for purposes of high deductible health plans in connection with health savings accounts.

What Do You Think?

How would you vote?

Referandom Vote

Vote to see the result.

Where the Bill Stands

  1. Introduced, done
  2. Committee, done
  3. Floor Vote, done
  4. Outcome, current stage

What This Bill Does

This bill provides statutory authority for guidance from the Internal Revenue Service (IRS) that expands the types of preventive care that may be offered under a high deductible health plan (HDHP) without requiring a deductible or with a deductible below the minimum threshold.

Under current law, to be considered health savings account-eligible, an HDHP must have a deductible above a certain minimum threshold amount, which is adjusted annually. However, an HDHP may cover certain types of preventive care without requiring a deductible or with a deductible below the minimum threshold.

The IRS issued guidance expanding the types of preventive care that may be covered by an HDHP without requiring a deductible or with a deductible below the minimum threshold to include

  • angiotensin converting enzyme inhibitors for individuals with congestive heart failure, diabetes, or coronary artery disease;
  • anti-resorptive therapy for individuals with osteoporosis or osteopenia;
  • beta-blockers for individuals with congestive heart failure or coronary artery disease;
  • blood pressure monitors for individuals with hypertension;
  • inhaled corticosteroids and peak flow meters for individuals with asthma;
  • insulin and other glucose lowering agents, retinopathy screening, glucometers, and hemoglobin A1c testing for individuals with diabetes;
  • international normalized ratio testing for individuals with liver disease or bleeding disorders;
  • low-density lipoprotein testing for individuals with heart disease;
  • statins for individuals with heart disease or diabetes; and
  • selective serotonin reuptake inhibitors for individuals with depression.

The bill provides statutory authority for the IRS's guidance.

Sponsors

Related Documents

Timeline

  1. SenateReceived in the Senate and Read twice and referred to the Committee on Finance.
  2. House floor actionsMr. Smith (MO) moved to suspend the rules and pass the bill.
  3. Passed the House
  4. Library of CongressIntroduced in House
  5. House floor actionsReferred to the House Committee on Ways and Means.
  6. Introduced
  7. Committee

Comments

Comments with insults, hate speech or personal information are removed.